Recruiting studies: Stargardt Disease Type 1 Stgd1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
Phase 1/Phase 2 · 10 location(s) · Ascidian Therapeutics, Inc · NCT06467344 Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease
Phase 1/Phase 2 · 1 location(s) · VeonGen Therapeutics GmbH · NCT07002398 An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Au
Phase N/A · 20 location(s) · Splice Bio · NCT06435000 Phase 1 Study of C.001 in Retinal Degeneration
Phase 1 · 1 location(s) · Cellio Therapeutics Inc · NCT07594236 Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients
Phase 1/Phase 2 · 3 location(s) · Ray Therapeutics, Inc. · NCT07439887 Study of ALK-001 on the Progression of Stargardt Disease
Phase 3 · 5 location(s) · Alkeus Pharmaceuticals, Inc. · NCT07419334 Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Phase N/A · 8 location(s) · Ascidian Therapeutics, Inc · NCT06445322 A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficac
Phase 1/Phase 2 · 5 location(s) · Splice Bio · NCT06942572 An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease
EARLY_Phase 1 · 1 location(s) · HuidaGene Therapeutics Co., Ltd. · NCT07063251

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.